Skip to content

PTHS PTHS Accrued Expenses

Accrued Expenses at other companies

Cumberland Pharmaceuticals logo
Cumberland PharmaceuticalsCPIX
$12.98M+15.7%
Scilex Holding Company logo
Scilex Holding CompanySCLX
$255K-99.8%
Journey Medical Corporation logo
Journey Medical CorporationDERM
$472K+18.3%
Opko Health logo
Opko HealthOPK
$83.48M-26.3%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$1.41M-58.6%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$8.73M+62.1%

Other financials

Income statement

See full
Revenue$10.9M
Gross profit$9.2M
Operating income-$13.1M-614%
Net income-$10.2M-420%
EPS (diluted)-$3.09+3.7%

Balance sheet

See full
Cash & equivalents$32.0M+24,250%
Total debt$29.6M
Total equity$35.1M+937%
Total assets$145.4M+15,855%

Cash flow

See full
Operating cash flow-$13.1M-1,977%
CapEx$194.0K
Free cash flow-$13.3M-2,008%

Valuation

See full
Market cap$98.22M+92.4%
Enterprise value$95.89M
P/S3.6×

Profitability

See full
Gross margin79.6%
Operating margin-157.7%
Net margin-186.2%
FCF margin-60.8%

Returns & leverage

See full
Return on equity-333.8%
Debt / equity0.8×
Current ratio2.8×+2.6×

Where this comes from

Reported directly by PTHS in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: PTHS’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTHS's accrued expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PTHS's accrued expenses?
PTHS (PTHS) reported accrued expenses of $1.93M in Q1 2026.
What is the long-term trend for PTHS's accrued expenses?
Over 3 years (2022 to 2025), PTHS's accrued expenses has grown at a 150.2% compound annual growth rate (CAGR), from $221.88K to $3.48M.
What does accrued expenses mean?
Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.